Adam Havey

Amministratore Delegato presso Emergent Travel Health, Inc.

Technology Services

Profilo

Adam Havey is the founder of GuardLlama, Inc., which was founded in 2015.
He is currently the Chief Executive Officer at Emergent Travel Health, Inc.

Posizioni attive di Adam Havey

Società	Posizione	Inizio
Emergent Travel Health, Inc. Emergent Travel Health, Inc. Internet Software/ServicesTechnology Services Emergent Travel Health, Inc. develops vaccines against infectious diseases. The firm develops vaccines against typhoid, cholera, hepatitis, anthrax, and other infectious diseases. Its proprietary adenoviral-based technology platform enables the rapid development of oral vaccines that can target viral or bacterial protein antigen. The company was founded by Kenneth Kelley and Daniel R. Henderson in 2007 and is headquartered in San Diego, CA.	Amministratore Delegato	-

Tutte le posizioni attive di Adam Havey

Precedenti posizioni note di Adam Havey

Società	Posizione	Fine
GuardLlama, Inc. GuardLlama, Inc. Packaged SoftwareTechnology Services Guard Llama, Inc. develops GPS location finder applications and devices. The company was founded by Dominick Blando, Joe Parisi and Havey Adam in 2015 and is headquartered in Chicago, IL.	Fondatore	-

Vedi nel dettaglio l'esperienza di Adam Havey

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Adam Havey

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	2
GuardLlama, Inc. GuardLlama, Inc. Packaged SoftwareTechnology Services Guard Llama, Inc. develops GPS location finder applications and devices. The company was founded by Dominick Blando, Joe Parisi and Havey Adam in 2015 and is headquartered in Chicago, IL.	Technology Services
Emergent Travel Health, Inc. Emergent Travel Health, Inc. Internet Software/ServicesTechnology Services Emergent Travel Health, Inc. develops vaccines against infectious diseases. The firm develops vaccines against typhoid, cholera, hepatitis, anthrax, and other infectious diseases. Its proprietary adenoviral-based technology platform enables the rapid development of oral vaccines that can target viral or bacterial protein antigen. The company was founded by Kenneth Kelley and Daniel R. Henderson in 2007 and is headquartered in San Diego, CA.	Technology Services